Alberta's Health Expertise and Infrastructure

Cardiometabolic Cardiometabolic

Alberta Diabetes Institute (ADI): is a research facility dedicated to translating discovery science into health solutions for the prevention, treatment and cure of diabetes. The ADI uses a multidisciplinary approach, bringing together leading researchers from diverse fields of expertise in a state-of-the-art facility on the University of Alberta Campus.

Edmonton Protocol for Diabetes: new treatment method uses islet cells from donor pancreases and a new combination of anti-rejection drugs. The cells are injected into the patient's portal vein in a non-surgical procedure. The cells then migrate to the liver where they produce sufficient insulin to free the patient from their daily routine of insulin injections and blood sugar testing.

Libin Cardiovascular Institute of Alberta: The Libin Cardiovascular Institute of Alberta is a 'virtual institute' in that its purpose is to coordinate and integrate cardiovascular services in southern Alberta. It is an entity of Alberta Health Service - Calgary Zone and the University of Calgary with more than 150 research and clinician members. It coordinates all cardiovascular science research, education and patient care across both AHS-C and UCalgary, serving a population of 2 million people in Southern Alberta, Saskatchewan and Eastern British Columbia.

Mazankowski Alberta Heart Institute: provides a full range of heart care services, with a special focus on prevention of heart disease and complex heart care, such as pediatric cardiac surgery and heart transplantation.



 Health Product Validation and Services Health Product Validation and Services

Alberta Cancer Clinical Trials (ACCT): provides a single point of contact to navigate the two key Clinical Trials Units in Alberta – The Cross Cancer Institute Clinical Trials Unit in Edmonton and Tom Baker Cancer Centre Clinical Trials Unit in Calgary. It also provides a central hub for communications, collaboration and coordination of clinical trial activities within the province of Alberta where treatment is provided for 45,000 patients diagnosed with cancer each year.

Alberta Health Services – Strategic Clinical Networks: Strategic Clinical Networks (SCNs) are creating improvements within focused areas of health care. To get the most out of our health care system, AHS has developed networks of people who are passionate and knowledgeable about specific areas of health, challenging them to find new and innovative ways of delivering care that will provide better quality, better outcomes and better value for every Albertan. Current SCNs:

Glenrose Rehabilitation Hospital Foundation – Courage in Motion Centre: The Centre is the Foundation's $4.4 million initiative to create a place where new beginnings are born and nurtured using the latest advances in rehabilitation equipment combined with leading- edge technology. Think robotics. Think virtual reality. Think simulation and gaming. Think real world bionics.

Health Sciences Council: The Health Sciences Council was established at the University of Alberta in the mid-1980s as a formal administrative arrangement through which the health science faculties could strengthen collaboration between equals. The council comprises the deans from faculties and schools with health sciences activities, and has academic and administrative responsibility for the Health Sciences Education and Research Commons (HSERC) and the Edmonton Clinic Health Academy.

Institute for Reconstructive Sciences in Medicine (iRSM): is an internationally recognized clinical and research institute focused on medical reconstructive sciences.

Northern Alberta Clinical Trials and Research Centre (NACTRC): provides pharmaceutical and research-intensive companies with access to high-quality, cost-efficient clinical trial research.

W21C (Ward of the 21st Century): serves as a site for prototype testing, product validation and design of healthcare delivery pathways for innovative medical technologies.

Zymetrix: An essential support service for researchers and corporations creating new biomedical technologies and products. Zymetrix consists of leading experts in the testing and development of biomaterials, engineered tissues, and medical devices. It provides: Contract testing services, Advanced training in tissue testing and specialized equipment usage, and Contract research & partnership opportunities in product development. Zymetrix is located within the Bose Biomaterials and Tissue Engineering Technology Development Centre at the University of Calgary.



Infectious Disease Infectious Disease

Alberta Glycomics Centre: The Centre comprises of a team of highly motivated individuals whose research interests span a multidisciplinary array of biological processes and technologies specific to carbohydrate research. The fields of chemistry, biology, medicine, and engineering are dynamically integrated as experts in areas such as carbohydrate synthesis, protein-carbohydrate interactions, glycoengineering, drug discovery, vaccine development, mass spectrometry, and X-ray crystallography work together to explore carbohydrate science. Currently, 10 principal investigators conduct their research as part of the Glycomics Centre.

Bacterial Pathogensis Research Group: The Bacterial Pathogenesis Research Group (BPRG) is a research and educational group in the Emerging Infectious Disease theme of the Institute of Infection, Immunity and Inflammation. The BPRG is comprised of scientists whose teams work to understand molecular mechanisms of bacterial diseases and develop vaccines or therapeutic targets for disease intervention. The major areas of research focus include pathogen-host interactions, virulence gene regulation, vaccine development, zoonotic diseases, bacterial communication, DNA replication and biofilm formation in chronic infections.

Li Ka Shing Institute of Virology: The Li Ka Shing Institute of Virology was created in 2010 through the combined gifts of $25-million from the Li Ka Shing (Canada) Foundation and $52.5-million from the Government of Alberta and incorporates researchers from the Alberta Institute for Viral Immunology and the Centre of Excellence for Viral Hepatitis Research. This entity brings together clinicians and basic scientists to study the development of hepatitis vaccines and antiviral therapies, animal models and cell culture models, genetic based population studies, epidemiological studies of populations at risk, and programs to reduce fatal outcomes of viral hepatitis infection.



 Medical Imaging/Technology Medical Imaging/Technology

Edmonton PET Centre: The Centre currently has 2 dedicated PET scanners in the department of diagnostic imaging. The scanners are used to provide images of the physiological and metabolic status of disease that can be overlaid with an anatomical image provided by the CT scanner. The Centre also includes Injection Suites, Radiopharmaceutical Manufacturing Labs, as well as several on-site dedicated research labs for the development of new PET radiotracers and their subsequent in vitro and in vivo evaluation.

The Experimental Imaging Centre: The Centre was established in March 2002 to serve as a critical resource in the development of multidisciplinary research programs using high-field magnetic resonance imaging (MRI) based in the Faculty of Medicine at the University of Calgary.

Health Sciences Education and Research Commons (HSERC) Simulation Centre: Test your new medical technologies and equipment in specialized environments which recreate a variety of health care settings including emergency crash scenes, acute hospital care and specialized procedures so you can assess how your innovation will be utilized in practice.

Peter S. Allen MR Research Centre: The Peter S. Allen MR Research Centre is 100% research dedicated, state-of-the-art facility of Department of Biomedical Engineering, Faculty of Medicine and Dentistry, University of Alberta. It is a home of three full-body MRI systems (1.5T, 3T and 4.7T) backed by a group of very skilled and enthusiastic professionals and provides a wide range of possibilities in magnetic resonance research and clinical research applications.

Stephensen CMR Centre: The Stephenson Cardiovascular CMR Centre at the Libin Cardiovascular Institute of Alberta is a diagnostic facility dedicated exclusively to Cardiovascular Magnetic Resonance (CMR).



Neurology Neurology

Albertaneuro: Campus Alberta Neuroscience (albertaneuro) is a province-wide network of ~250 research professionals working in neuroscience and mental health: from early brain development to Alzheimer’s and from foundational biological research to clinical, therapeutic and system application of new knowledge. Albertaneuro is designed to deliver significant, positive, measureable and lasting impact through the generation and translation of knowledge. Albertaneuro’s aim is to establish the province of Alberta as a centre of neuroscience excellence, impact and innovation on the international stage. Albertaneuro is led by a steering committee from the Universities of Alberta, Calgary, and Lethbridge.

Canadian Centre for Behavioural Neuroscience (CCBN): is a world-class research facility for behavioural neuroscience research and has a broad range of research interests, including the neural mechanisms of learning, brain plasticity, and recovery of function, brain development, and brain disease.

Hotchkiss Brain Institute (HBI): Neuroscience is a rapidly evolving science, with recent discoveries that are improving the lives of many suffering from debilitating illnesses. The Hotchkiss Brain Institute is a world leader in aligning scientists and clinicians to coordinate their research, and, ultimately, enhance patient care. The Institute has centred its research on three key objectives: Regeneration, Repair and Recovery, Neural Signaling and Mental Disorders, Imaging and Advanced Technologies.



Omics Omics

Metabolomics Innovation Centre (TMIC): This national laboratory processes 1000’s of samples each year from dozens of labs around the world and it is renowned for its capacity to do quantitative metabolomics. It houses more than $15 million in state-of-the-art metabolomics instrumentation and is home to more than $6 million in large-scale metabolomics projects including the Metabolomic Tricorder Project and Metabolomic Devices for Companion Diagnostics and Personalized Medicine

Genome Alberta is a publicly funded not-for-profit corporation that initiates, funds, and manages genomics research and partnerships. Genome Alberta strives to be the leading source of information and administration related to genomics, proteomics, bioinformatics and bioethics research in Alberta. It is dedicated to informing students, researchers, research organizations, our partners, and the public regarding opportunities and challenges in genomics and proteomics, and in encouraging the development of a Life Sciences research industry in Alberta.



Oncology Oncology

Alberta Cancer Clinical Trials (ACCT) provides a single point of contact to navigate the two key Clinical Trials Units in Alberta – The Cross Cancer Institute Clinical Trials Unit in Edmonton and Tom Baker Cancer Centre Clinical Trials Unit in Calgary. It also provides a central hub for communications, collaboration and coordination of clinical trial activities within the province of Alberta where treatment is provided for 45,000 patients diagnosed with cancer each year.

The Alberta Cancer Registry: The Alberta Cancer Registry is a population-based registry, established in 1942, that records and maintains data on all new cancer cases and cancer deaths occurring in the province. The Alberta Cancer Registry is operated by the Alberta Health Services-Cancer Care and is mandated by the Regional Health Authorities Act of Alberta . By recording information on cancer cases and cancer-related deaths over the past few decades, the Alberta Cancer Registry has been able to compare cancer rates in Alberta with other provinces and countries. The Registry also shares data with health care providers throughout the province so that they can plan effective prevention, treatment and research programs. The registry data can also help identify Albertans who may be eligible for participation in research studies that have been approved by a Research Ethics Board as designated in the Health Information Act.

CancerControl Alberta reduces the impact of cancer on all Albertans and provides expert care and support for patients from their first symptom to survivorship. Our goal is to be to be a leader in cancer prevention, diagnosis, treatment, survivorship and palliative care, all on a foundation of world-class research.

Cross Cancer Institute: The Institute in Edmonton is the comprehensive cancer centre for northern Alberta and a lead centre for the province-wide prevention, research and treatment program. The Cross Cancer Institute provides advanced medical and supportive cancer care, patient and professional education, and conducts research through the Alberta Cancer Research Institute.

Tom Baker Cancer Centre: The Centre in Calgary is the comprehensive cancer centre for southern Alberta and a lead centre for the province-wide prevention, research and treatment program. The Tom Baker Cancer Centre provides advanced medical and supportive cancer care, patient and professional education, and conducts research through the Alberta Cancer Research Institute.